Positron Emission Tomography (PET) is a medical imaging technology that is used to detect and diagnose medical conditions in the body. It is a type of scan that produces three-dimensional images of the body by measuring the distribution of radioactive tracers in the patient's body. PET scans have numerous medical applications. These scans are primarily used in the early detection of cancer, by detecting cancerous tumors before they have had a chance to grow and spread. They are also commonly used to diagnose a range of cardiovascular conditions, impacting the heart and blood vessels. In addition, they are used to detect and diagnose several neurological disorders as well as certain types of brain tumors. The underlying process of PET scans is based on the administration of small amounts of a radioactive tracer, such as fluorodeoxyglucose (FDG) to the patient. This tracer is composed of a carbohydrate component and a radioactive particle. The tracer is administered intravenously and is then absorbed by the tissues of the body, flowing through the bloodstream. Once the tracer has been absorbed, the patient is placed in position in the PET scanner and the images are generated. The images collected measure the radioactivity absorbed by the patient's body tissues, often by detection of gamma rays from the radiation emitted by the tracer. The images can be used to visualize and detect any abnormal growths in the body, such as tumors, and enable subsequent diagnosis and treatment. Overall, positon emissions tomography is an invaluable technology for detecting and diagnosing a number of medical conditions, ranging from cancer to cardiovascular and neurological disorders.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States